MMP9 and triple-A syndrome: Additionally, a study found that in patients undergoing open AAA repair surgery, the combined use of HMG-CoA reductase inhibitors (such as simvastatin) and cholesterol absorption inhibitors (such as ezetimibe) can effectively reduce MMP-9 and IL-6 levels in the aortic wall (29).